FDA Policy on Pharmacogenomic Data in Drug Development

› ›

Author: Janet Woodcock

Position: M.D., Deputy Commissioner for Operations

Pages: 91-102

Linked as:

Document options

Extract

FDA Policy on Pharmacogenomic Data in Drug Development

No longer available (Autolink)

See the full content of this document